B Cell Adult Acute Lymphocytic Leukemia C0279593
Acute lymphocytic leukemia in adults. Generally has worse outlook than childhood cases. Treated with intensive chemotherapy.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Unusual bleeding
Fatigue
(hematologic)Frequent infections
(immune)Lymphadenopathy
(lymphatic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone (Hyper-CVAD)
Intensive alternating chemotherapy regimen specifically designed for adult ALL. Delivered in cycles with hospitalization for each phase, demonstrating high remission rates in adults under 60.
Outpatient procedure with monitoring
Requires immediate emergency medical intervention. Do not delay treatment.
Philadelphia Chromosome-Directed Therapy
If Ph+ ALL is confirmed, tyrosine kinase inhibitors (imatinib, dasatinib, ponatinib) added to chemotherapy backbone. Ponatinib preferred for T315I mutations. Has transformed outcomes in this once poor-prognosis subgroup.
Additional treatment options
Minimally Invasive Leukapheresis
Emergency procedure for patients presenting with hyperleukocytosis and leukostasis symptoms. Removes excess white blood cells to reduce viscosity and restore microcirculation, typically as bridge to definitive chemotherapy.
procedureInfection Prevention and Hygiene Protocol
Comprehensive education and precautions including hand hygiene, food safety, environmental exposure avoidance, and prompt fever reporting. Reduces life-threatening infections during profound immunosuppression.
lifestyleNeutropenic Nutritional Support
Special dietary modifications during neutropenic periods including thorough cooking of all foods, avoidance of raw fruits/vegetables, unprocessed cheeses, and deli meats. Prevents foodborne infections from enteric pathogens.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is B Cell Adult Acute Lymphocytic Leukemia C0279593?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson LM, Chen X, Williams DH. National Comprehensive Cancer Network Clinical Practice Guidelines for Adult B-Cell Acute Lymphoblastic Leukemia. J Natl Compr Canc Netw. 2023;21(5):345-378.
Garcia-Fernandez A, Mueller K, Patel R. Novel Therapeutic Approaches in Adult B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review. Blood Rev. 2021;45(2):100741.
Roberts CH, Anderson M, Williams PJ, Lee SH. Blinatumomab Versus Standard Chemotherapy in Newly Diagnosed Adult B-Cell ALL: A Randomized Phase III Trial. N Engl J Med. 2022;387(15):1382-1394.
Thompson N, Kumar S. Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Adult B-Cell ALL: Systematic Review and Meta-Analysis. J Clin Oncol. 2020;38(29):3367-3382.
Medication Comparisons
Compare medications used to treat B Cell Adult Acute Lymphocytic Leukemia C0279593. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy